- This event has passed.
BC Cancer Research Seminar Series: Dr. James D. Johnson
December 9, 2019 @ 12:00 pm - 1:00 pm
BC Cancer Research Seminar Series presents a seminar:
Dr. James D. Johnson, Ph.D.
Professor Department of Cellular, Physiological Sciences and Surgery, University of British Columbia
Date: Monday, December 9, 2019
Time: 12:00pm to 1:00pm
Location: Gordon & Leslie Diamond Family Theatre, BC Cancer Research Centre, 675 W.10th Ave.
Videolinked to: FVC – room 2035, VIC – room #3, CSI – Shuswap room, CN – Salmon room, UBC Biomedical Research Centre – room 351, Michael Smith Labs – room 303, C&W – room K4-142
Title: Hyperinsulinemia in insulin resistance, obesity, longevity and cancer
Abstract:
Jim Johnson is a Professor in the Department of Cellular and Physiological Sciences, and the Department of Surgery at the University of British Columbia, in Vancouver Canada. His laboratory is housed in the Diabetes Research Group at the Life Sciences Institute. Prior to arriving in Vancouver, he was a post-doctoral fellow at Washington University in St. Louis, under the guidance of Profs. Ken Polonsky and Stanley Misler. Johnson obtained his PhD from the University of Alberta under the supervision of Prof. John Chang, completing a thesis focused on the mechanisms controlling the release of gonadotropin and growth hormone from the goldfish pituitary.
Bio:
A leader in the fundamental biology of pancreatic islets, insulin action, diabetes and related conditions, Prof. Johnson is the author of >125 peer-reviewed articles since starting in 2000. Prof. Johnson is Editor-in-Chief of the journal Islets. Prof. Johnson has won several awards, including being named the top Canadian researcher under 45 by the Canadian Diabetes Association in 2016.
In 2016, Prof. Johnson co-founded the Institute for Personalized Therapeutic Nutrition based out of Vancouver, Canada, and is co-CSO of this non-profit dedicated to research, clinical care, and advocacy for people employing personalized diets to decrease the burden of type 2 diabetes.
From 2016-2018, Prof. Johnson was the inaugural Director of the Novo Nordisk Research Centre in Oxford, a hybrid academic-industry Institute focused on the fundamental biology of type 2 diabetes and target discovery. Prof. Johnson remains Visiting Professor of Integrated Physiology in the Radcliff Department of Medicine and Senior Fellow at Harris-Manchester College, in Oxford.
Prof. Johnson is dedicated to training the next generation of scientists; many of his former trainees hold faculty positions or senior scientist positions in industry. Prof. Johnson is actively involved in science outreach on Twitter @JimJohnsonSci.
Sponsored by: BC Cancer Foundation
Hosted by: Dr. Julian Lum
